Jörg Möller, MD joined Bayer AG in 1993 from academic medicine at Ruhr-University Bochum, Germany. Initially being responsible for global late stage development of a cardio-vascular compound, he became responsible for cardiovascular new business development in 1996. From 1998 until the end of 2001, Dr. Möller held positions of increasing responsibility in clinical development at Bayer Corporation, West Haven, CT (USA) and at Bayer Inc., HealthCare Division, Toronto (Canada).
In March 2003, Dr. Möller became Head, Global Clinical Development at Bayer HealthCare AG, Pharmaceuticals Division.
Dr. Jörg Möller was named Head of Global Development on Feb 1, 2014 and became a member of the Pharmaceuticals Division Executive Committee in 2016.
Since Jan 1, 2018 he leads the combined Pharmaceuticals Research & Development organization.